Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis

The tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to...

Full description

Saved in:
Bibliographic Details
Main Authors: Zikun Huang, Qing Luo, Cuifen Xiong, Haiyan Zhu, Chao Yu, Jianqing Xu, Yiping Peng, Junming Li, Aiping Le
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2025.2459132
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825208833785462784
author Zikun Huang
Qing Luo
Cuifen Xiong
Haiyan Zhu
Chao Yu
Jianqing Xu
Yiping Peng
Junming Li
Aiping Le
author_facet Zikun Huang
Qing Luo
Cuifen Xiong
Haiyan Zhu
Chao Yu
Jianqing Xu
Yiping Peng
Junming Li
Aiping Le
author_sort Zikun Huang
collection DOAJ
description The tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases. The differential expression profiles of tsRNAs in serum from active TB patients and healthy controls were analyzed by high-throughput sequencing. A total of 905 subjects were prospectively recruited for our study from three different cohorts. Levels of tsRNA-Gly-CCC-2, tsRNA-Gly-GCC-1, and tsRNA-Lys-CTT-2-M2 were significantly elevated in the serum of TB patients compared to non-TB individuals, showing a correlation with lung injury severity and acid-fast bacilli grades in TB patients. The accuracy of the three-tsRNA biosignature for TB diagnosis was evaluated in the training (n = 289), test (n = 124), and prediction (n = 292) groups. By utilizing cross-validation with a random forest algorithm approach, the training cohort achieved a sensitivity of 100% and specificity of 100%. The test cohort exhibited a sensitivity of 75.8% and a specificity of 91.2%. Within the prediction group, the sensitivity and specificity were 73.1% and 92.5%, respectively. The three-tsRNA biosignature generally decreased within 3 months of treatment and then remained stable. In conclusion, the three-tsRNA biosignature might serve as biomarker to diagnose TB and to monitor the effectiveness of treatment in a high-burden TB clinical setting.
format Article
id doaj-art-129809fd163f48ce886cc530ef927d74
institution Kabale University
issn 2222-1751
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-129809fd163f48ce886cc530ef927d742025-02-06T17:51:53ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512025-12-0114110.1080/22221751.2025.2459132Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosisZikun Huang0Qing Luo1Cuifen Xiong2Haiyan Zhu3Chao Yu4Jianqing Xu5Yiping Peng6Junming Li7Aiping Le8Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaDepartment of Tuberculosis, Jiangxi Chest Hospital, Nanchang, People’s Republic of China.Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaKey Laboratory of Jiangxi Province for Transfusion Medicine, Department of Blood Transfusion, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of ChinaThe tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases. The differential expression profiles of tsRNAs in serum from active TB patients and healthy controls were analyzed by high-throughput sequencing. A total of 905 subjects were prospectively recruited for our study from three different cohorts. Levels of tsRNA-Gly-CCC-2, tsRNA-Gly-GCC-1, and tsRNA-Lys-CTT-2-M2 were significantly elevated in the serum of TB patients compared to non-TB individuals, showing a correlation with lung injury severity and acid-fast bacilli grades in TB patients. The accuracy of the three-tsRNA biosignature for TB diagnosis was evaluated in the training (n = 289), test (n = 124), and prediction (n = 292) groups. By utilizing cross-validation with a random forest algorithm approach, the training cohort achieved a sensitivity of 100% and specificity of 100%. The test cohort exhibited a sensitivity of 75.8% and a specificity of 91.2%. Within the prediction group, the sensitivity and specificity were 73.1% and 92.5%, respectively. The three-tsRNA biosignature generally decreased within 3 months of treatment and then remained stable. In conclusion, the three-tsRNA biosignature might serve as biomarker to diagnose TB and to monitor the effectiveness of treatment in a high-burden TB clinical setting.https://www.tandfonline.com/doi/10.1080/22221751.2025.2459132Tuberculosisbiomarkerdiagnosistransfer RNA-derived small RNAsbiosignature
spellingShingle Zikun Huang
Qing Luo
Cuifen Xiong
Haiyan Zhu
Chao Yu
Jianqing Xu
Yiping Peng
Junming Li
Aiping Le
Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
Emerging Microbes and Infections
Tuberculosis
biomarker
diagnosis
transfer RNA-derived small RNAs
biosignature
title Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
title_full Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
title_fullStr Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
title_full_unstemmed Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
title_short Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis
title_sort identification of serum trna derived small rnas biosignature for diagnosis of tuberculosis
topic Tuberculosis
biomarker
diagnosis
transfer RNA-derived small RNAs
biosignature
url https://www.tandfonline.com/doi/10.1080/22221751.2025.2459132
work_keys_str_mv AT zikunhuang identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT qingluo identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT cuifenxiong identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT haiyanzhu identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT chaoyu identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT jianqingxu identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT yipingpeng identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT junmingli identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis
AT aipingle identificationofserumtrnaderivedsmallrnasbiosignaturefordiagnosisoftuberculosis